文献速递流行病学与生物统计医学人工智能与信息学

扩展的Bootstrap MARS结合组LASSO用于异质性治疗效应估计

Extension of Bootstrap MARS With Group LASSO for Heterogeneous Treatment Effect Estimation.
PubMed 文献 · Stat Med · 2026-01-01

真实世界数据(RWD)中异质性治疗效应(HTE)估计对精准医学有重要意义。作者在bagging因果多元自适应回归样条(BCM)基础上提出收缩因果bootstrap MARS方法:先用转换结局bootstrap抽样MARS估计基函数,再通过组LASSO优化模型并估计参数。模拟显示该方法在多数场景下均方误差和偏倚改善,并在ACTG 175数据集上验证了实用性。

要点

  • 提出收缩因果bootstrap MARS方法用于真实世界数据中的异质性治疗效应估计。
  • 方法先用转换结局bootstrap抽样MARS估计基函数,再用组LASSO优化模型和估计参数。
  • 模拟显示多数场景下均方误差和偏倚改善,并在ACTG 175数据集上验证实用性。

核心结论

  • 所提出的收缩因果bootstrap MARS方法在多数模拟场景下均方误差和偏倚较BCM有所改善,并在ACTG 175数据集上验证了实际适用性。

研究设计与样本

  • 方法学研究:在bagging因果多元自适应回归样条(BCM)基础上提出收缩因果bootstrap MARS方法,并通过模拟和ACTG 175数据集验证。
  • 方法框架:先用转换结局bootstrap抽样MARS估计基函数,再通过组最小绝对收缩和选择算子(LASSO)优化模型并估计参数。

主要发现

  • 模拟显示所提方法在多数场景下均方误差和偏倚改善。
  • 在ACTG 175数据集上验证了该方法的实际适用性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In recent years, clinical data obtained from patient surveys and medical records have become increasingly pivotal in medical data science. These clinical data, collectively referred to as "real-world data (RWD)," are anticipated to play a key role in observational studies of specific diseases and in advancing personalized or precision medicine by identifying effective treatments for particular patient subgroups. Consequently, the estimation of heterogeneous treatment effects (HTEs) using RWD has garnered substantial attention. HTE estimation meaningfully contributes to precision medicine by enabling clinicians to make informed treatment decisions tailored to individual patient characteristics. Various treatment effect models for observational studies highlight the robust performance of bagging causal multivariate adaptive regression splines (MARS) (BCM). However, despite the notable efficacy of BCM, there remains potential for refinement. Here, we introduce a novel treatment effect model, the shrinkage causal bootstrap MARS method, which builds upon the following framework: initially, basis functions are estimated using transformed outcome bootstrap sampling MARS, followed by optimization of the model and parameter estimation via the group least absolute shrinkage and selection operator (LASSO) method. Our simulations demonstrate that the proposed method achieves improved mean square error and bias across most scenarios. Additionally, we validate the practical applicability of the method by implementing it on the ACTG 175 dataset.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. He G, Wan K, Shimokawa T, et al. Extension of Bootstrap MARS With Group LASSO for Heterogeneous Treatment Effect Estimation. Stat Med. 2026. PMID: 41572614. doi:10.1002/sim.70370

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。